IDEXX Laboratories Inc (IDXX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, IDEXX Laboratories Inc (IDXX) has a cash flow conversion efficiency ratio of 0.171x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($266.25 Million) by net assets ($1.56 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See IDEXX Laboratories Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
IDEXX Laboratories Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how IDEXX Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
IDEXX Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IDEXX Laboratories Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MSCI Inc
NYSE:MSCI
|
-0.111x |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
0.080x |
|
East Money Information Co Ltd
SHE:300059
|
-0.037x |
|
Polski Koncern Naftowy ORLEN SA
WAR:PKN
|
0.089x |
|
Constellation Software Inc.
TO:CSU
|
0.167x |
|
Bayerische Motoren Werke Aktiengesellschaft
XETRA:BMW
|
0.017x |
|
STMicroelectronics N.V
F:SGMR
|
0.029x |
|
Quanta Computer Inc
TW:2382
|
-0.337x |
Annual Cash Flow Conversion Efficiency for IDEXX Laboratories Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of IDEXX Laboratories Inc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see IDEXX Laboratories Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.61 Billion | $1.18 Billion | 0.734x | +26.01% |
| 2024-12-31 | $1.60 Billion | $929.00 Million | 0.582x | -4.64% |
| 2023-12-31 | $1.48 Billion | $906.51 Million | 0.611x | -31.54% |
| 2022-12-31 | $608.74 Million | $542.98 Million | 0.892x | -18.54% |
| 2021-12-31 | $689.99 Million | $755.55 Million | 1.095x | +6.92% |
| 2020-12-31 | $632.79 Million | $648.06 Million | 1.024x | -60.34% |
| 2019-12-31 | $177.82 Million | $459.16 Million | 2.582x | +105.96% |
| 2018-12-31 | $-9.23 Million | $400.08 Million | -43.332x | -525.03% |
| 2017-12-31 | $-53.84 Million | $373.28 Million | -6.933x | -124.23% |
| 2016-12-31 | $-108.21 Million | $334.57 Million | -3.092x | -20.03% |
| 2015-12-31 | $-84.00 Million | $216.36 Million | -2.576x | -228.43% |
| 2014-12-31 | $117.59 Million | $235.85 Million | 2.006x | +322.52% |
| 2013-12-31 | $518.21 Million | $246.00 Million | 0.475x | +31.16% |
| 2012-12-31 | $636.26 Million | $230.28 Million | 0.362x | -11.51% |
| 2011-12-31 | $539.59 Million | $220.70 Million | 0.409x | +31.34% |
| 2010-12-31 | $574.28 Million | $178.83 Million | 0.311x | -7.76% |
| 2009-12-31 | $514.58 Million | $173.72 Million | 0.338x | +3.20% |
| 2008-12-31 | $438.19 Million | $143.34 Million | 0.327x | +6.11% |
| 2007-12-31 | $438.32 Million | $135.12 Million | 0.308x | +15.05% |
| 2006-12-31 | $409.86 Million | $109.83 Million | 0.268x | -15.09% |
| 2005-12-31 | $369.31 Million | $116.55 Million | 0.316x | +31.58% |
| 2004-12-31 | $397.66 Million | $95.38 Million | 0.240x | -15.39% |
| 2003-12-31 | $413.29 Million | $117.16 Million | 0.283x | -6.39% |
| 2002-12-31 | $340.97 Million | $103.25 Million | 0.303x | +97.07% |
| 2001-12-31 | $301.73 Million | $46.36 Million | 0.154x | +42.42% |
| 2000-12-31 | $261.75 Million | $28.24 Million | 0.108x | -41.69% |
| 1999-12-31 | $284.30 Million | $52.60 Million | 0.185x | +23.53% |
| 1998-12-31 | $307.80 Million | $46.10 Million | 0.150x | +235.82% |
| 1997-12-31 | $302.70 Million | $13.50 Million | 0.045x | +79.90% |
| 1996-12-31 | $322.70 Million | $8.00 Million | 0.025x | +1.75% |
| 1995-12-31 | $279.10 Million | $6.80 Million | 0.024x | -83.57% |
| 1994-12-31 | $99.80 Million | $14.80 Million | 0.148x | +67.54% |
| 1993-12-31 | $83.60 Million | $7.40 Million | 0.089x | +6331.58% |
| 1992-12-31 | $70.40 Million | $-100.00K | -0.001x | -101.18% |
| 1991-12-31 | $31.50 Million | $3.80 Million | 0.121x | -- |
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urin… Read more